Pluri (PLUR) Cash & Equivalents (2009 - 2026)
Pluri (PLUR) recorded Cash & Equivalents of $3.53 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 40.1% from $5.9 million a year earlier.
Powered by 
Analysis
Pluri (PLUR) Cash & Equivalents (2009 - 2026) Analysis & Trends
Starting with fiscal Q1 2011, Pluri's Cash & Equivalents history includes 62 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -35.6% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $5.9 million in FY2025 (-13.1%), $6.78 million in FY2024 (+8.4%), $6.26 million in FY2023 (-45.2%) and $11.41 million in FY2022 (-64.2%).
- The fiscal Q4 2026 figure is the lowest quarterly Cash & Equivalents since fiscal Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with an average decline of 10.9%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 145.7% in fiscal Q2 2022, against a decline of 81.6% in fiscal Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Pluri | 12.12 Mn | -26.94 Mn | 196,000.00 | 3.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53 Mn |
| Mar 31, 2026 | 3.42 Mn |
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.26 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | 7.99 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 4.58 Mn |
| Dec 31, 2022 | 10.17 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 24.93 Mn |
| Dec 31, 2021 | 19.22 Mn |
| Sep 30, 2021 | 15.22 Mn |
API Access
Pluri Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PLUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();